sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
gatagctgaatttgggactatgt | 2072 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatagctgaatttgggactatgt | 2072 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatagctgaatttgggactatgt | 2072 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gatagctgaatttgggactatgt | 2072 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acttgtctcccagtgggtcctgt | 6449 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acttgtctcccagtgggtcctgt | 6449 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acttgtctcccagtgggtcctgt | 6449 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acttgtctcccagtgggtcctgt | 6449 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaccagtcgtcccagaataact | 8050 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaccagtcgtcccagaataact | 8050 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaccagtcgtcccagaataact | 8050 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaccagtcgtcccagaataact | 8050 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acaaagagtgccaggaagggtgg | 6128 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acaaagagtgccaggaagggtgg | 6128 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acaaagagtgccaggaagggtgg | 6128 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
acaaagagtgccaggaagggtgg | 6128 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 2513 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 2513 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 3188 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 3188 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 2783 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
cgccagtagcttggctgccta | 2783 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
cgccagtagcttggctgccta | 2513 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 2513 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 2783 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 2783 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cgccagtagcttggctgccta | 3188 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
cgccagtagcttggctgccta | 3188 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-... |
atgctgaaatatgtttcaaca | 4642 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 4642 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 4642 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgctgaaatatgtttcaaca | 4642 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgctgaaatatgtttcaaca | 3833 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgctgaaatatgtttcaaca | 3833 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgctgaaatatgtttcaaca | 3295 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 3295 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 3295 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 3295 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 3833 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgctgaaatatgtttcaaca | 3833 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaagccaacaatccttggcctgc | 8247 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaagccaacaatccttggcctgc | 8247 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaagccaacaatccttggcctgc | 8247 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaagccaacaatccttggcctgc | 8247 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gttgccttgtatttccagagaac | 4453 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gttgccttgtatttccagagaac | 4453 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gttgccttgtatttccagagaac | 4453 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gttgccttgtatttccagagaac | 4453 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 1368 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atctcagaaccatatctgtta | 1368 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atctcagaaccatatctgtta | 2177 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 2177 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 830 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 830 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 1368 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 1368 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 830 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 830 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atctcagaaccatatctgtta | 2177 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atctcagaaccatatctgtta | 2177 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
tcacagactccacttcagcct | 7128 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcacagactccacttcagcct | 7128 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcacagactccacttcagcct | 7128 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 7128 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 6714 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcacagactccacttcagcct | 6714 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcacagactccacttcagcct | 5652 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 5652 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 5652 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 5652 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 6714 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcacagactccacttcagcct | 6714 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 3949 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 3949 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 4758 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 4758 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 3411 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 3411 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 3411 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 3411 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atgatactgaaagtggtgata | 4758 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgatactgaaagtggtgata | 4758 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgatactgaaagtggtgata | 3949 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
atgatactgaaagtggtgata | 3949 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphorothioate","norInfo":[{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphorothioate"]},{"norI... |
ctgctttgctgggtagtgagctc | 4575 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgctttgctgggtagtgagctc | 4575 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgctttgctgggtagtgagctc | 4575 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctgctttgctgggtagtgagctc | 4575 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagtctgtgacagtagcaaagc | 6107 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagtctgtgacagtagcaaagc | 6107 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagtctgtgacagtagcaaagc | 6107 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["5->5"],"infos":["OTHER"]},{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["7->7"],"infos":["OTHER"]}] |
agagtctgtgacagtagcaaagc | 6107 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["5->5"],"infos":["OTHER"]},{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["7->7"],"infos":["OTHER"]}] |
ttcaaatagtcatataaggagcc | 1216 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttcaaatagtcatataaggagcc | 1216 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttcaaatagtcatataaggagcc | 1754 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttcaaatagtcatataaggagcc | 1754 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttcaaatagtcatataaggagcc | 1216 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttcaaatagtcatataaggagcc | 1216 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttcaaatagtcatataaggagcc | 1754 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
ttcaaatagtcatataaggagcc | 1754 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.